DavidSethAaronsonMD

PubMed

• Modifying Effects of Genetic Variations on the Association Between Dietary Isothiocyanate Exposure and Non-muscle Invasive Bladder Cancer Prognosis in the Be-Well Study.
  Zinian Wang, Marilyn L Kwan, Reina Haque, Prashant K Singh, Maciej Goniewicz, Rachel Pratt, Valerie S Lee, Janise M Roh, Isaac J Ergas, Kimberly L Cannavale, Ronald K ...> ;Molecular Nutrition & Food Research. 2024 Apr 1
• Environmental and Occupational Exposures and Prognosis in Patients with Non-Muscle Invasive Bladder Cancer in the Be-Well Study.
  Wang, Z., Kwan, M., Haque, R., Pratt, R., Lee, V., Roh, J., Ergas, I., Cannavale, K., Loo, R., Aaronson, D., Quesenberry, C., Ambrosone, C., Kushi, L., Tang, L.> ;American Journal of Epidemiology. 2023 Dec 5
• 1 citations
  Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non-muscle-invasive bladder cancer: findings ...
  Zinian Wang, Marilyn L Kwan, Reina Haque, Maciej Goniewicz, Rachel Pratt, Valerie S Lee, Janise M Roh, Isaac J Ergas, Kimberly L Cannavale, Ronald K Loo, David S Aaron...> ;The American Journal of Clinical Nutrition. 2023 Jun 1
• 2 citations
  Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective Cohort.
  Vidit Sharma, Karim Chamie, Mark Schoenberg, Valerie S Lee, Katherine Fero, Patrick Lec, Julie R Munneke, David S Aaronson, Lawrence H Kushi, Charles P Quesenberry, Li...> ;Urology. 2023 Mar 1
• 6 citations
  Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study.
  Marilyn L Kwan, Reina Haque, Kelly C Young-Wolff, Valerie S Lee, Janise M Roh, Isaac J Ergas, Zinian Wang, Kimberly L Cannavale, Christine B Ambrosone, Ronald K Loo, D...> ;JAMA Network Open. 2022 Nov 1
• 2 citations
  Psychological predictors of delayed active treatment following active surveillance for low-risk prostate cancer: The Patient REported outcomes for Prostate cARE prospe...
  Kathryn L Taylor, George Luta, Vasiliki Zotou, Tania Lobo, Richard M Hoffman, Kimberly M Davis, Arnold L Potosky, Tengfei Li, David Aaronson, Stephen K Van Den Eeden> ;BJUI Compass. 2022 May 1
• 11 citations
  A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility.
  Nima C. Emami, Taylor B. Cavazos, Sara R. Rashkin, Rebecca E. Graff, Caroline G. Tai, Joel Mefford, Linda Kachuri, Clint L Cario, Eunice Wan, Simon Wong, David S. Aaro...> ;Cancer Research. 2021 Apr 1
• 1 citations
  Catheter Balloon-Trauma: Design, Development and Ex-Vivo Studies Using Intact Human Penis Specimens
  Hanson Zhao, David S. Aaronson, Andrew Chen, Maurice M. Garcia> ;Urology. 2020 Sep 1
• 11 citations
  Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.
  Richard M. Hoffman, Tania Lobo, Stephen K. Van Den Eeden, Kimberly Davis, George Luta, Amethyst Leimpeter, David S. Aaronson, David F. Penson, Kathryn L. Taylor> ;Medical Decision Making. 2019 Oct 21
• AUTHOR REPLY.
  Marilyn L Kwan, Kim N Danforth, David S Aaronson, Matthew D Wagner, Stephen G Williams, Carmit K McMullen> ;Urology. 2019 Mar 1
• 3 citations
  Tighter Blood Pressure Control Is Associated with Lower Incidence of Erectile Dysfunction in Hypertensive Men.
  Wayland Hsiao, Ruth Ann Bertsch, Yun-Yi Hung, David S. Aaronson> ;The Journal of Sexual Medicine. 2019 Mar 1
• 10 citations
  The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer.
  Marilyn L. Kwan, Lawrence H. Kushi, Kim N. Danforth, Janise M. Roh, Isaac J. Ergas, Valerie S. Lee, Kimberly L. Cannavale, Teresa N. Harrison, Richard Contreras, Ronal...> ;Cancer Causes & Control. 2019 Jan 17
• 2 citations
  Factors That Influence Selectionof Urinary Diversion Among Bladder Cancer Patients in 3 Community-based Integrated Health Care Systems.
  Marilyn L. Kwan, Michael C. Leo, Kim N. Danforth, Sheila Weinmann, Valerie S. Lee, Julie R. Munneke, Joanna E. Bulkley, Maureen O'Keefe Rosetti, David K Yi, Matthew P....> ;Urology. 2019 Mar 1
• 7 citations
  Perioperative Intravesical Chemotherapy for Patients WithNon-Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommen...
  Devon K. Check, David S. Aaronson, Matthew E. Nielsen, Valerie S. Lee, Isaac J. Ergas, Janise M. Roh, Lawrence H. Kushi, Li Tang, Marilyn L. Kwan> ;Urology. 2019 Feb 1
• 5 citations
  Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer
  Marie C. Bradley, Yingjun Zhou, Andrew N. Freedman, Marianne Ulcickas Yood, Charles P Quesenbery, Reina Haque, Stephen K. Van Den Eeden, Andrea E. Cassidy-Bushrow, Dav...> ;Cancer Causes & Control. 2018 Jun 29
• 6 citations
  The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality.
  Lauren P. Wallner, Julia R. DiBello, Bonnie H. Li, Stephen K. Van Den Eeden, Sheila Weinmann, Debra P. Ritzwoller, Jill Abell, Ralph B. D'Agostino, Ronald K. Loo, Davi...> ;Urology. 2018 Jun 12
• 9 citations
  Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study
  Kathryn L. Taylor, George Luta, Richard M. Hoffman, Kimberly Davis, Tania Lobo, Yingjun Zhou, Amethyst Leimpeter, Jun Shan, Roxanne E. Jensen, David S. Aaronson, Steph...> ;Translational Behavioral Medicine. 2018 Mar 1
• 13 citations
  Decision-making processes among men with low-risk prostate cancer: A survey study.
  Richard M. Hoffman, Stephen K. Van Den Eeden, Kimberly Davis, Tania Lobo, George Luta, Jun Shan, David S. Aaronson, David F. Penson, Amethyst Leimpeter, Kathryn L. Taylor> ;Psycho-Oncology. 2018 Jan 1
• 14 citations
  Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.
  Alex Z. Fu, Huei-Ting Tsai, Reina Haque, Marianne Ulcickas Yood, Andrea E. Cassidy-Bushrow, Stephen K. Van Den Eeden, Nancy L. Keating, Matthew R. Smith, Yingjun Zhou,...> ;The Journal of Urology. 2017 Jun 1
• 4 citations
  Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer.
  Kimberly Davis, Paula G. Bellini, Charlotte J. Hagerman, Riley E. Zinar, Daniel Y. Leigh, Richard M. Hoffman, David S. Aaronson, Stephen K. Van Den Eeden, George Phili...> ;Urology. 2017 Sep 1
• 3 citations
  Physicians’ perspectives on the informational needs of low-risk prostate cancer patients
  Charlotte J. Hagerman, Paula G. Bellini, Kim M. Davis, Richard M. Hoffman, David S. Aaronson, Daniel Y. Leigh, Riley E. Zinar, David F. Penson, Stephen K. Van Den Eede...> ;Health Education Research. 2017 Apr 1
• 46 citations
  Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.
  Thomas J. Hoffmann, Michael N. Passarelli, Rebecca E. Graff, Nima C. Emami, Lori C. Sakoda, Eric Jorgenson, Laurel A. Habel, Jun Shan, Dilrini K. Ranatunga, Charles P....> ;Nature Communications. 2017 Jan 31
• 12 citations
  5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia
  Lauren P. Wallner, Julia R. DiBello, Bonnie H. Li, Stephen K. Van Den Eeden, Sheila Weinmann, Debra P. Ritzwoller, Jill Abell, Ralph B. D'Agostino, Ronald K. Loo, Davi...> ;Mayo Clinic Proceedings. 2016 Dec 1
• 11 citations
  Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observationa...
  Scott P. Kelly, Stephen K. Van Den Eeden, Richard M. Hoffman, David S. Aaronson, Tania Lobo, George Luta, Amethyst D. Leimpter, Jun Shan, Arnold L. Potosky, Kathryn L....> ;The Journal of Urology. 2016 Sep 1
• 30 citations
  Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer
  Kathryn L. Taylor, Richard M. Hoffman, Kimberly Davis, George Luta, Amethyst Leimpeter, Tania Lobo, Scott P. Kelly, Jun Shan, David S. Aaronson, Catherine Tomko, Amy J...> ;Cancer Epidemiology, Biomarkers & Prevention. 2016 Aug 1
• Join now to see all